2868-37-3COC(=O)C1CC1PKAHQJNJPDVTDP-UHFFFAOYSA-NMethyl cyclopropanecarboxylate is a methyl ester derived from cyclopropanecarboxylic acid. It is a methyl ester and a member of cyclopropanes. It is functionally related to a cyclopropanecarboxylic acid.
2868-37-3DTXSID3051967CHEBI:131412Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 35.6% (37 of 104) of reports.
Danger
H225 (53.8%): Highly Flammable liquid and vapor [Danger Flammable liquids]
P210, P233, P240, P241, P242, P243, P261, P262, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P316, P321, P330, P337+P317, P361+P364, P370+P378, P403+P233, P403+P235, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 104 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Chemical: Cyclopropanecarboxylic acid, methyl ester
REACH registered substance: Methyl cyclopropanecarboxylate (EC: 220-690-9)
UsesMethyl cyclopropane carboxylate is used as a reagent in the synthesis of N’thiazole and N-pyrazole based inhibitors of MAP kinase p38α.
UsesIt is primarily used an intermediate in the manufacture of pharmaceutical and agrochemical products. Methyl cyclopropane carboxylate is used as a reagent in the synthesis of N-thiazole and N-pyrazole based inhibitors of MAP kinase p38α.
DefinitionChEBI: Methyl cyclopropanecarboxylate is a methyl ester derived from cyclopropanecarboxylic acid. It is a methyl ester and a member of cyclopropanes. It is functionally related to a cyclopropanecarboxylic acid.